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The Joint EPUAP & EWMA 
Pressure Ulcer Prevention &  
Patient Safety Advocacy Project 
Pressure ulcers (PUs), also known as bed sores, pressure sores or pressure injury, are defined as: localized injury to the skin 
and/or underlying tissue usually over a bony 
prominence, as a result of pressure, or pressure 
in combination with shear (National Pressure 
Ulcer Advisory Panel [NPUAP], European 
Pressure Ulcer Advisory Panel [EPUAP], Pan 
Pacific Pressure Injury Alliance [PPPIA], 2014). 
These wounds range in severity from superficial 
tissue damage, to full scale tissue destruction 
(Beeckman et al, 2008). PUs occur most often 
in individuals who have activity or mobility 
problems and are exposed to prolonged periods 
of exposure to sustained pressure/shear forces 
(Gefen et al, 2008). Thus, pressure ulcers can occur 
in persons of any age, from the very young nursed 
in specialised intensive care units, to the very 
old, nursed in long stay settings (Schoonhoven 
et al, 2002; Schoonhoven et al, 2006). A recent 
report from the Organisation for Economic Co-
operation and Development (OECD) suggests 
that PUs are a significant threat to patient safety, 
with prevention being substantially cheaper than 
treatment (Slawomirski et al, 2017). 
The financial impact of PUs is a concern, 
as most but not all PUs can be avoided with 
appropriate risk assessment and use of 
interventions targeted at combating this risk 
(Moore and Cowman, 2014). However, despite 
this premise, it is estimated that approximately 
4% of the annual healthcare budget in Europe 
is being spent on PUs, with nursing time 
accounting for 41% of these costs (Posnett et al, 
2009). Pressure ulcers have also been shown 
to increase length of hospital stay, readmission 
and mortality rates (Lyder et al, 2012; Chan et 
al, 2013; Pokorná et al, 2017). Approximately 
15% of total hospital activity and expenditure 
is a direct result of adverse events. The most 
PROFESSOR ZENA MOORE 
Professor of Nursing and Head 
of the School of Nursing & 
Midwifery, Royal College of 
Surgeons in Ireland; European 
Pressure Ulcer Advisory Panel 
Trustee; Chair of the Joint 
EPUAP & EWMA Pressure 
Ulcer Prevention & Patient 
Safety Advocacy Project
PROFESSOR JOSE VERDU 
SORIANO 
Senior Lecturer and researcher 
at the Faculty of Health Sciences. 
University of Alicante. Spain; 
European Wound Management 
Association, Chair of the Joint 
EPUAP & EWMA Pressure 
Ulcer Prevention & Patient 
Safety Advocacy Project
PROFESSOR ANDREA 
POKORNÁ
Associate Professor, Department 
of Nursing, Faculty of Medicine, 
Masaryk University, Brno, 
European Wound Management 
Association, member of the Joint 
EPUAP & EWMA Pressure 
Ulcer Prevention & Patient 
Safety Advocacy Project  
Background: Pressure ulcers (PUs) are a common, costly, debilitating problem across 
all healthcare sectors, despite significant investment in education and training and 
use of human resources, equipment, and technological advancements. In recognising 
the persistent problem of PUs, the European Wound Management Association 
(EWMA) and the European Pressure Ulcer Advisory Panel (EPUAP) have created a 
group to work collectively on a specific project advocating for the prevention of PUs 
to be considered as a major health care and patient safety issue. Aim: The overall aim 
of the project is to establish a joint EPUAP-EWMA working group on PU prevention 
and engage in patient safety agendas at the European level as well as at the national 
level in selected European countries. Discussion: We are seeking to place prevention 
of PUs as a high priority on the patient safety agenda within the European Union 
(EU). To achieve this, given the lack of agreed methodology for incidence monitoring, 
we advocate for the use of standardised monitoring of PU prevalence, with targeted 
prevention measures to reduce prevalence, made available across the continuum of 
care. Conclusion: Adopting PU prevalence as a key measurement tool across the 
wider health care sector in the EU, will ensure that both adequate monitoring of 
prevalence and use of prevention can be achieved.
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burdensome adverse event types include venous 
thromboembolism (VTE), PUs, and infections 
(Slawomirski et al, 2017). Furthermore, the 
highest bed day losses are attributable to PUs and 
VTE (Slawomirski et al, 2017). 
Despite advances in technology, preventative 
aids and increased financial expenditure, PUs 
remain a large scale debilitating concern (Moore 
et al, 2013). Prevalence rates, a measure of the 
number of persons with a pressure ulcer at a 
given point in time, in a specific population 
(International guidelines, 2009), range from 8.8% 
to 53.2% and incidence rates vary from 7%–71.6% 
across Europe, the United States of America 
(USA) and Canada (Moore and Cowman, 2012). 
Furthermore, 72% of all PUs occur in the over 
65 year age group (Russo et al, 2006). From a 
community perspective, a recent study has 
identified that 22% of those living at home, but 
under the care of the community nurse, had a PU 
(Skerritt and Moore, 2014). 
PUs have a large impact on those affected; the 
wounds may become infected and can be foul 
smelling (Moore and Cowman, 2009). Pain is 
one of the most commonly cited complaints 
and worryingly, this pain is often intractable 
and is exacerbated by some of the treatments 
employed to manage the wound (Gorecki et al, 
2011). It is clearly evident that people with PUs 
have a significantly lower health-related quality 
of life than those without PUs (Essex et al, 2009). 
Annually, in the UK, of the six most common 
adverse events, the greatest burden was exerted 
by PUs equating to 13,780 healthy life years lost 
(Slawomirski et al, 2017). Worryingly, patients 
can die as a direct result of a PU, indeed, global 
mortality directly attributable to PUs has 
increased from 32.1% (95% CI: 26.0–38.5) to 42.6% 
(95% CI: 32.9–48.7) from 2000–2010 (Lozano et 
al, 2010).
THE EWMA/EPUAP ADVOCACY PROJECT 
The topic of patient safety has for some years 
been high on the European Commission health 
care agenda. At the EU level, as well as at the 
national levels of most European nations, 
considerable investments have been made by 
healthcare authorities to establish organisations 
and programmes addressing the patient safety 
agenda. Looking at the patient safety agenda 
from a wound care perspective, the topic of PU 
has always been central due to the fact that most 
PUs are preventable if the patient is identified 
and managed correctly by health care staff. 
Consequently, both EPUAP and EWMA have 
separately, over some years, been advocating for 
the prevention of PUs to be considered as a major 
health care and patient safety issue. Whereas 
EPUAP, in particular, has strongly supported 
the annual ‘Stop the Pressure Ulcer’ campaign, 
EWMA has, in collaboration with the Eucomed 
Advanced Wound Care Sector, a working group 
within Eucomed  known as the ‘Voice of the 
Medical Technology Industry in Europe’ that 
ensures that the implications of wounds for both 
the patient and the clinician are understood — 
engaged in raising attention in the European 
Parliament and European Commission.
Neither EPUAP or EWMA, nor the established 
national patient safety organisations have, to 
our knowledge, so far, taken significant steps to 
establish links or collaboration between their 
approaches and activities. Thus, while healthcare 
professionals, mainly nurses, at the local level 
and national level, are actively engaged in PU 
prevention and the patient safety agenda, no 
collaboration, or sharing of knowledge has been 
established at the organisational level of the 
established national patient safety organisations. 
THE PROJECT’S AIM
The overall aim of the project is to establish a joint 
EPUAP-EWMA working group for PU prevention 
which will engage with patient safety agendas at 
the European level as well as at the national level 
in selected European countries. 
Given that PUs are a common, costly, highly 
prevalent public health issue, which affect the 
population across all ages and across all health 
care settings, a greater emphasis on prevention 
is essential to reduce the burden of PUs. Thus, 
we are suggesting that the prevention of PUs is 
placed as a high priority on the patient safety 
agenda within the EU. Prevalence rates provide 
an indication of the burden of the problem of PUs, 
whereas incidence rates, a measure of the number 
of new PUs that develop in a specific population 
over a period of time, are often used to measure 
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So far, the accomplishments include:
A working group has been established in January 2016, with representation from both EWMA and EPUAP
The project has secured unrestricted educational grants from: 
 n 3M, Hartmann, Mölnlycke and Smith & Nephew.
Continuous screening of press announcements/calendars of the European Commission and European Parliament 
has been undertaken by Instinctif Partners, to make sure that EPUAP and EWMA are aware of and seek to influence 
scheduled activities that may be used to advocate for improved PU prevention and wound care
Meetings between Professor Lisette Schoonhoven and the chair of OECD Health Care Quality Indicators expert group 
have taken place since November 2016
EWMA and EPUAP met with Mr Matthias Schuppe, European Commission policy officer in charge of patient safety and 
Mr Gerhard Steffes, Policy Officer for the European Commission Directorate, in Luxembourg, in May 2017. The meeting 
objectives were to: 
Call upon the European Commission to look at the patient safety agenda from a wound care perspective	 	
	 n Raise awareness of the costs of pressure ulcer and the value of prevention 
	 n Present the two organisations and the advocacy project	 	 	
	 n Discuss how they could support the European Commission’s work on patient safety.
Joint presentations have been planned for the annual conferences of EWMA and EPUAP. The first of these took place at 
the EWMA Amsterdam conference 3-5 May 2017
 A systematic review of European PU prevalence has been undertaken and results will be presented at the EPUAP 2017 
conference, 20–22 September in Belfast. 
All activities are reported on in more detail at the joint EWMA/EPUAP sessions at the annual conferences of EWMA 
and EPUAP. The next presentation will take place at the EPUAP 2017 conference, 20–22 September in Belfast.
Further information and updates about the project activities are available at http://bit.ly/2uCQzNO
Box 1. The Joint EPUAP & EWMA Pressure Ulcer Prevention & Patient Safety Advocacy Project’s 
achievements 
the quality of care provided to individual users 
of the health service (International guidelines, 
2009). However, given the lack of standardised 
methodology for the collection of incidence data, 
and the very real challenges that this poses for 
adopting incidence monitoring across Europe, we 
advocate for the use of standardised monitoring 
of PU prevalence. Indeed, there is already 
inexistence, a minimum data set, developed by 
EPUAP (Vanderwee et al, 2007), which provides 
for a validated methodology to employ across 
the EU. Further, we advocate monitoring the 
application of targeted prevention measures to 
reduce incidence, such as use of the SSKIN bundle 
(Gibbons et al, 2006), which should be made 
available across the continuum of care. Finally, 
adopting PU prevalence, as a key measure across 
the wider healthcare sector in the EU, will, as a 
first step, ensure that adequate monitoring of both 
prevalence and use, or lack thereof, prevention 
can be identified. From these data, elements of 
care delivery, which require improvements, may 
be identified and interventions employed in a 
targeted manner. Furthermore, sharing data will 
lead to sharing experiences and skills, however, 
international cooperation in PUs prevalence as 
previous, prevention and treatment is challenged 
by the lack of national registries (Pokorná et al, 
2016). Box 1 lists the goals, thus far, reached. 
CONCLUSIONS
The concept of patient safety is synonymous 
with healthcare delivery today, and in the EU, 
a particular emphasis is placed on monitoring 
adverse events (Health Information and Quality 
Authority, 2013). The UN Committee on 
Economic, Social, and Cultural Rights argues 
that the right to health contains four elements: 
availability, accessibility, acceptability, and 
quality (World Health Organization, 2012). 
For individuals using the health service the 
EU, the right to health means that they should 
expect to have access to treatments that are 
timely, appropriate, patient centred and of the 
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highest quality (Jha et al, 2013). Furthermore, 
it is imperative that care is delivered within an 
environment that is conducive to achieving safety 
standards and where measures are in place to 
avoid the risk of exposure to an adverse event 
(Rossi, 2013).
It is evident, however, that despite the drive for 
safer, better care, adverse events are common. 
Indeed, the European Commission estimates that 
between 8% and 12% of patients entering a hospital 
setting suffers from an adverse event while 
receiving treatment during hospitalisation (Rossi, 
2013). Furthermore, almost 18.1% of patients 
in acute care, annually in the EU, acquire a PU 
(Vanderwee et al, 2007). Furthermore, despite 
the longevity of experience in the assessment 
and management of individuals with PUs, their 
prevalence and incidence remains high (Moore et 
al, 2013). The challenge here lies in the fact that 
in many cases the PU could have been avoided 
(Moore, 2013). Quality improvement is the centre 
focus of this project, therefore, the output, a 
reduction in the occurrence of PUs, is of particular 
importance to users of the health service across 
the EU.   Wuk
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